Therapeutic management of hyperglycaemic hyperosmolar syndrome

Expert Opinion on Pharmacotherapy

Volumn 6, Issue 11, 2005, Pages 1841-1849

  Milionis, Haralampos J ^a   Elisaf, Moses S ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Dehydration; Fluid therapy; Hyperglycaemic crises; Hyperglycaemic hyperosmolar syndrome; Management; Nonketotic coma

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ASPARAGINASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORPROMAZINE; CHLORTALIDONE; CIMETIDINE; DIAZOXIDE; ETACRYNIC ACID; GLUCOSE; HEPARIN; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; LOXAPINE; PHENYTOIN; PHOSPHATE; POTASSIUM; PROPRANOLOL; SODIUM; STEROID;

ADULT; AGE; ANAMNESIS; BRAIN HEMORRHAGE; CHOLECYSTITIS; CLINICAL FEATURE; DEHYDRATION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROLYTE BALANCE; FLUID THERAPY; GASTROINTESTINAL HEMORRHAGE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPEROSMOLALITY; HYPEROSMOLARITY; HYPOPHOSPHATEMIA; INCIDENCE; INTRAVENOUS ADMINISTRATION; LABORATORY TEST; MORTALITY; NONKETOTIC DIABETIC COMA; OUTCOMES RESEARCH; PATIENT CARE; PATIENT MONITORING; PHOSPHATE BLOOD LEVEL; PHYSICAL EXAMINATION; PNEUMONIA; POTASSIUM BLOOD LEVEL; PYELONEPHRITIS; REVIEW; RISK FACTOR; SODIUM BLOOD LEVEL; THROMBOSIS;

ADULT; DEHYDRATION; DIABETES MELLITUS, TYPE 2; FLUID THERAPY; HUMANS; HYPERGLYCEMIC HYPEROSMOLAR NONKETOTIC COMA; HYPOGLYCEMIC AGENTS; INSULIN; POTASSIUM; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; SYNDROME; WATER-ELECTROLYTE IMBALANCE;

EID: 25444433364     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.6.11.1841     Document Type: Review

References (43)

1. AMERICAN DIABETES ASSOCIATION: Hyperglycemic crisesin patients with diabetes mellitus. Diabetes Care (2001) 24(11):1988-1996.
2. ROSE BD: Hyperosmolal states-hyperglycemia. In: Clinical physiology of acid-base and electrolyte disorders (5th edn). Rose BD, Post TW (Eds). MacGraw Hill, New York (2001):794-821.
3. MILIONIS HJ, LIAMIS GL, ELISAF MS: Hyperosmolar syndrome in a patient with uncontrolled diabetes mellitus. Am. J. Kidney Dis. (2001) 37:E41.
4. CHIASSON J-L, ARIS-JILWAN N, BELANGER R et al.: Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Can. Med. Assoc. J. (2003) 168(7):859-866.
5. ARIEFF AI, CARROLL HJ: Nonketotic hyperosmolar coma with hyperglycemia: clinical features, pathophysiology, renal function, acid-base balance, plasma-cerebrospinal fluid equilibria and the effects of therapy in 37 cases. Medicine (1972) 51:73-94.
6. MILIONIS HJ, LIAMIS G, ELISAF MS: Appropriate treatment of hypernatraemia in diabetic hyperglycaemic hyperosmolar syndrome. J. Intern. Med. (2001) 249:273-276.
7. DAUGIRDAS JT, KRONFOL NO, TZALALOUKAS AH, ING TS: Hyperosmolar coma: cellular dehydration and the serum sodium concentration. Ann. Intern. Med. (1989) 110:855-857.
8. KITABCHI AE, UMPIERREZ GE, MURPHY MB et al.: Management of hyperglycemic crises in patients with diabetes. Diabetes Care (2001) 24(1):131-153.
9. FREIDENBERG GR, KOSNIK EJ, SOTOS JF: Hyperglycemic coma after suprasellar surgery. N. Engl. J. Med. (1980) 303:863.
10. CAPES SE, HUNT D, MALMBERG K, GERSTEIN HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet (2000) 355:773-778.
11. FINBERG L: Hypernatremic (hypertonic) dehydration in infants. N. Engl. J. Med. (1973) 289:196-198.
12. FULOP M: The treatment of severely uncontrolled diabetes mellitus. Adv. Intern. Med. (1984) 29:327-356.
13. UMPIERREZ GE, KHAJAVI M, KITABCHI RA: Review: diabetic ketoacidosis and hyperglycaemic nonketotic syndrome. Am. J. Med. Sci. (1996) 311:225-233.
14. ENNIS ED, STAHL EJVB, KREISBERG RA: The hyperosmolar hyperglycemic syndrome. Diabetes Rev. (1994) 2:115-126.
15. KITABCHI AE, UMPIERREZ GE, MURPHY MB et al.: Hyperglycemic crises in patients with diabetes mellitus. Diabetes Care (2004) 27(Suppl. 1):S94-S102.
16. WASSERMAN DH, VRANIC M: Interaction between insulin and counterregulatory hormones in control of substrate utilization in health and diabetes during exercise. Diabetes Metab. Rev. (1986) 1:359-384.
17. PRESS M, TAMBORLANE WV, SHERWIN RS: Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. N. Engl. J. Med. (1984) 310:810-815.
18. LORBER D: Nonketotic hypertonicity in diabetes mellitus. Med. Clin. North. Am. (1995) 79:39-52.
19. LIAMIS G, GIANOUTSOS C, ELISAF MS: Hyperosmolar nonketotic syndrome with hypernatremia: how can we monitor treatment. Diabetes Metab. (2000) 26:403-405.
20. KATZ MA: Hyperglycemia-induced hyponatremia: calculation of expected serum sodium depression. N. Engl. J. Med. (1973) 289:843-844.
21. HILLIER TA, ABBOTT RD, BARRETT EJ: Hyponatremia: evaluating the correction factor for hyperglycemia. Am. J. Med. (1999) 106:399-403.
22. WEISBERG LS: Pseudohyponatremia: a reappraisal. Am. J. Med. (1989) 86:315-318.
23. ELISAF M, PAPAGALANIS ND, SIAMOPOULOS KC: The importance of serum sodium in the symptomatology of hyperglycemic-induced hypertonicity. J. Nephrol. (1993) 6:202-205.
24. ADROGUE HJ, MADIAS NE: Changes in plasma potassium concentration during acute acid-base disturbances. Am. J. Med. (1981) 71:456-467.
25. VIBERTI GC: Glucose-induced hyperkalaemia: a hazard for diabetics? Lancet (1978) 1:690-691.
26. +-ATPase and glucose transport in soleus muscle. Am. J. Physiol. (1987) 252:E492-E499.
27. KEBLER R, MCDONALD FD, CADNAPAPHORNCHAI P: Dynamic changes in serum phosphorus levels in diabetic ketoacidosis. Am. J. Med. (1985) 79:571-576.
28. MANGE K, MATSUURA D, CIZMAN B et al.: Language guiding therapy: the case of dehydration versus volume depletion. Ann. Intern. Med. (1997) 127:848-853.
29. ADROGUE HJ, BARRERO J, EKNOYAN G: Salutary effects of modest fluid replacement in the treatment of adults with diabetic ketoacidosis. Use in patients without extreme fluid deficit. J. Am. Med. Assoc. (1989) 262:2108-2113.
30. PAGE MM, ALBERTI KG, GREENWOOD R et al.: Treatment of diabetic coma with continuous low-dose insulin infusion. Br. Med. J. (1974) 2:687-690.
31. BROWN PM, TOMPKINS CV, JUUL S, SONKSEN PH: Mechanism of action of insulin in diabetic patients: A dose-related effect on glucose production and utilisation. Br. Med. J. (1978) 1:1239-1242.
32. ROSENTHAL NR, BARRETT EJ: An assessment of insulin action in hyperosmolar hyperglycemic nonketotic diabetic patients. J. Clin. Endocrinol. Metab. (1985) 60:607-610.
33. FISHER JN, SHAHSHAHANI MM, KITABCHI AE: Diabetic ketoacidosis: low-dose insulin therapy by various routes. N. Engl. J. Med. (1977) 297:238-241.
34. WALDHAUSL W, KLEINBERGER G, KORN A, DUDCZA R, BRATUSCH-MARRAIN P, NOWATNY P: Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration. Diabetes (1979) 28:577-584.
35. BRATUSCH-MARRAIN PR, KOMAJATI M, WALDHAUSAL W: The effect of hyperosmolarity on glucose metabolism. Pract. Cardiol. (1985) 11:153-163.
36. DURR JA, HOFFMAN WH, SKLAR AH, EL GAMMAL T, STEINHART CM: Correlates of brain edema in uncontrolled IDDM. Diabetes (1992) 41:627-632.
37. MILIONIS HJ, DIMOS G, ELISAF MS: Severe hyperkalemia in association with diabetic ketoacidosis in a patient presenting with severe generalized muscle weakness. Nephrol. Dial. Transplant. (2003) 18:198-200.
38. KREISBERG RA: Phosphorus deficiency and hypophosphatemia. Hosp. Pract. (1977) 12:121-128.
39. ZIPF WB, BACON GF, SPENCER ML, KELCH RP, HOPWOOD NJ, HAWKER CD: Hypocalcemia, hypomagnesemia, and transient hypoparathyroidism during therapy with potassium phosphate in diabetic ketoacidosis. Diabetes Care (1979) 2:265-268.
40. FISHER JN, KITABCHI AE: A randomised study of phosphate therapy in the treatment of diabetic ketoacidosis. J. Clin. Endocrinol. Metab. (1983) 57:177-180.
41. CARR ME: Diabetes mellitus: a hypercoagulable state. J. Diabet. Complications (2001) 15:44-54.
42. KIAN K, EIGER G: Anticoagulant therapy in hyperosmolar non-ketotic diabetic coma. Diabetic Med. (2003) 20:603.
43. LEVINE MN, RASKOB G, LANDERFELD S, KEARON C: Hemorrhagic complications of anticoagulant treatment. Chest (2001) 119:108S-121S.